BackgroundCheck.run
Search For

George B Teaney, 621304 Old Forge Rd, Oxford, PA 19363

George Teaney Phones & Addresses

1304 Old Forge Rd, Oxford, PA 19363   

Cambridge, MD   

Wilmington, DE   

New Castle, DE   

Newark, DE   

Beaufort, SC   

Social networks

George B Teaney

Linkedin

Work

Company: Siemens healthcare Aug 2007 Position: Staff biochemist

Skills

Elisa • Biotechnology • Lifesciences • Biochemistry • Immunoassays • Assay Development • Microbiology • Medical Devices • Validation • Fda • Molecular Biology • R&D • Life Sciences

Industries

Hospital & Health Care

Mentions for George B Teaney

George Teaney resumes & CV records

Resumes

George Teaney Photo 1

Staff Biochemist

Location:
Oxford, PA
Industry:
Hospital & Health Care
Work:
Siemens Healthcare
Staff Biochemist
Sdix Llc - An Origene Company 1992 - 2006
Senior Scientist
Skills:
Elisa, Biotechnology, Lifesciences, Biochemistry, Immunoassays, Assay Development, Microbiology, Medical Devices, Validation, Fda, Molecular Biology, R&D, Life Sciences

Publications & IP owners

Us Patents

Bacteriophages As Selective Agents

US Patent:
2008021, Sep 4, 2008
Filed:
Feb 21, 2008
Appl. No.:
12/034765
Inventors:
James W. Stave - Bear DE, US
George B. Teaney - Oxford PA, US
Assignee:
Strategic Diagnostics Inc. - Newark DE
International Classification:
C12Q 1/70
C12N 7/00
US Classification:
435 5, 4352351
Abstract:
Compositions containing bacteriophages and methods of using bacteriophages in microorganism detection assays and microbial growth and plating media are disclosed. The lytic ability of these phages to control the growth of non-target populations provides superior sensitivity and specificity to detection assays and reduces false negative and false positive results. The removal of contaminating bacteria reduces the microbial competition for nutrients in the growth media thereby increasing the efficiency and productivity of the culture. The phage treatment of the sample increases the proportion of target microorganisms in the sample over contaminating bacteria thereby requiring less time for enrichment to obtain a significant signal improving overall signal to noise ratio in assays and providing for higher yield of end product in microbiological production systems.

Bacteriophages As Selective Agents

US Patent:
2006009, May 4, 2006
Filed:
Oct 31, 2005
Appl. No.:
11/262859
Inventors:
James Stave - Bear DE, US
George Teaney - Oxford PA, US
International Classification:
C12Q 1/04
C12N 7/00
US Classification:
435034000, 435235100
Abstract:
Compositions containing bacteriophages and methods of using bacteriophages in microorganism detection assays and microbial growth and plating media are disclosed. The lytic ability of these phages to control the growth of non-target populations provides superior sensitivity and specificity to detection assays and reduces false negative and false positive results. The removal of contaminating bacteria reduces the microbial competition for nutrients in the growth media thereby increasing the efficiency and productivity of the culture. The phage treatment of the sample increases the proportion of target microorganisms in the sample over contaminating bacteria thereby requiring less time for enrichment to obtain a significant signal improving overall signal to noise ratio in assays and providing for higher yield of end product in microbiological production systems.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.